Condition
Type 2 Respiratory Failure
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed3
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06694870CompletedPrimary
Transcutaneous CO2 Measurement - From Hospital to Home
NCT05698641CompletedPrimary
Efficiency of HFNC Vs NIV in Patient With Acute Type 2 RF
NCT03481543Not ApplicableTerminated
Effectiveness of Bronchodilator Nebulization With and Without Noninvasive Ventilation in COPD
NCT04020627Not ApplicableCompletedPrimary
BIPAP vs CPAP Effects on Type 2 Respiratory Failure Patients
Showing all 4 trials